A Pilot Study of Exendin-4 in Alzheimer s Disease

Trial Profile

A Pilot Study of Exendin-4 in Alzheimer s Disease

Phase of Trial: Phase II

Latest Information Update: 26 Feb 2018

At a glance

  • Drugs Exenatide (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Jan 2018 Status changed from completed to discontinued.
    • 19 Nov 2016 Status changed from recruiting to completed.
    • 03 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top